High-resolution metabolic imaging of high-grade gliomas using 7T-CRT-FID-MRSI

[Display omitted] •We demonstrated reliable and fast whole-brain 3D-MRSI of high-grade gliomas at 7T.•tCho, Gln, and Gly were increased in contrast-enhancing tumor tissue.•Results corresponded well to clinical data, but show more differentiated images.•We found cases of heterogeneity in metabolic im...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:NeuroImage clinical Jg. 28; S. 102433
Hauptverfasser: Hangel, Gilbert, Cadrien, Cornelius, Lazen, Philipp, Furtner, Julia, Lipka, Alexandra, Hečková, Eva, Hingerl, Lukas, Motyka, Stanislav, Gruber, Stephan, Strasser, Bernhard, Kiesel, Barbara, Mischkulnig, Mario, Preusser, Matthias, Roetzer, Thomas, Wöhrer, Adelheid, Widhalm, Georg, Rössler, Karl, Trattnig, Siegfried, Bogner, Wolfgang
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Netherlands Elsevier Inc 01.01.2020
Elsevier
Schlagworte:
tCr
PT
Gln
Tau
IDH
Glu
UHF
Gly
Cys
MM
HGG
FOV
ROI
2HG
NCE
VOI
T1w
Ser
CRT
SAR
WET
SVS
SNR
WM
T2w
GSH
WT
FID
CE
GM
NEC
TME
NAA
TE
Ctn
PET
TR
ISSN:2213-1582, 2213-1582
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[Display omitted] •We demonstrated reliable and fast whole-brain 3D-MRSI of high-grade gliomas at 7T.•tCho, Gln, and Gly were increased in contrast-enhancing tumor tissue.•Results corresponded well to clinical data, but show more differentiated images.•We found cases of heterogeneity in metabolic images not visible in clinical imaging. Successful neurosurgical intervention in gliomas depends on the precision of the preoperative definition of the tumor and its margins since a safe maximum resection translates into a better patient outcome. Metabolic high-resolution imaging might result in improved presurgical tumor characterization, and thus optimized glioma resection. To this end, we validated the performance of a fast high-resolution whole-brain 3D-magnetic resonance spectroscopic imaging (MRSI) method at 7T in a patient cohort of 23 high-grade gliomas (HGG). We preoperatively measured 23 patients with histologically verified HGGs (17 male, 8 female, age 53 ± 15) with an MRSI sequence based on concentric ring trajectories with a 64 × 64 × 39 measurement matrix, and a 3.4 × 3.4 × 3.4 mm3 nominal voxel volume in 15 min. Quantification used a basis-set of 17 components including N-acetyl-aspartate (NAA), total choline (tCho), total creatine (tCr), glutamate (Glu), glutamine (Gln), glycine (Gly) and 2-hydroxyglutarate (2HG). The resultant metabolic images were evaluated for their reliability as well as their quality and compared to spatially segmented tumor regions-of-interest (necrosis, contrast-enhanced, non-contrast enhanced + edema, peritumoral) based on clinical data and also compared to histopathology (e.g., grade, IDH-status). Eighteen of the patient measurements were considered usable. In these patients, ten metabolites were quantified with acceptable quality. Gln, Gly, and tCho were increased and NAA and tCr decreased in nearly all tumor regions, with other metabolites such as serine, showing mixed trends. Overall, there was a reliable characterization of metabolic tumor areas. We also found heterogeneity in the metabolic images often continued into the peritumoral region. While 2HG could not be satisfyingly quantified, we found an increase of Glu in the contrast-enhancing region of IDH-wildtype HGGs and a decrease of Glu in IDH1-mutant HGGs. We successfully demonstrated high-resolution 7T 3D-MRSI in HGG patients, showing metabolic differences between tumor regions and peritumoral tissue for multiple metabolites. Increases of tCho, Gln (related to tumor metabolism), Gly (related to tumor proliferation), as well as decreases in NAA, tCr, and others, corresponded very well to clinical tumor segmentation, but were more heterogeneous and often extended into the peritumoral region.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2213-1582
2213-1582
DOI:10.1016/j.nicl.2020.102433